Gara Jalqabaatti › Luukemiya Mayiloodii Keessummaa
Qorannoo klinikaalii Luukemiya Mayiloodii Keessummaa Ameerikaa Keessatti hirmaatuu
Qorannoo 48 Luukemiya Mayiloodii Keessummaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 18
- Seattle, WAQorannoo 11
- New York City, NYQorannoo 11
- Detroit, MIQorannoo 6
- Birmingham, ALQorannoo 6
- Chicago, ILQorannoo 6
- Portland, ORQorannoo 6
- Philadelphia, PAQorannoo 6
- Baldwin Park, CAQorannoo 6
- Nashville, TNQorannoo 5
- Columbus, OHQorannoo 5
- Baltimore, MDQorannoo 5
- Atlanta, GAQorannoo 5
- Durham, NCQorannoo 5
- Boston, MAQorannoo 5
- Milwaukee, WIQorannoo 5
- Rochester, NYQorannoo 4
- Cincinnati, OHQorannoo 4
- Washington, DCQorannoo 4
- St. Louis, MOQorannoo 4
- Kansas City, MOQorannoo 4
- Augusta, GAQorannoo 4
- Mountain View, CAQorannoo 4
- Salt Lake City, UTQorannoo 3
- Orange, CAQorannoo 3
- Buffalo, NYQorannoo 3
- St. Petersburg, FLQorannoo 3
- Bridgeport, CTQorannoo 3
- Edison, NJQorannoo 3
- Cleveland, OHQorannoo 3
- Ann Arbor, MIQorannoo 3
- Sacramento, CAQorannoo 3
- Aurora, COQorannoo 3
- Miami, FLQorannoo 3
- Greenville, NCQorannoo 3
- Minneapolis, MNQorannoo 3
Naannoon
- AlabamaQorannoo 6
- ArizonaQorannoo 4
- CaliforniaQorannoo 10
- ColoradoQorannoo 4
- Distaarikii KoloombiyaaQorannoo 3
- FloridaQorannoo 7
- GeorgiaQorannoo 7
- IllinoisQorannoo 6
- IndianaQorannoo 3
- KansasQorannoo 5
- KentuckyQorannoo 3
- MarylandQorannoo 6
- MassachusettsQorannoo 5
- MichiganQorannoo 7
- MinnesotaQorannoo 4
- MissouriQorannoo 4
- NebraskaQorannoo 3
- New JerseyQorannoo 4
- New YorkQorannoo 15
- North CarolinaQorannoo 8
- OhioQorannoo 9
- OregonQorannoo 6
- PennsylvaniaQorannoo 7
- TennesseeQorannoo 5
- TexasQorannoo 18
- UtahQorannoo 3
- VirginiaQorannoo 4
- WashingtonQorannoo 11
- WisconsinQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06817720Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 1 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04925479Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06236724Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06398457Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 21 hanga 65 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Namoota walitti qabaa jiraSadarkaa 1
1 Day – 21 Years · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Namoota walitti qabaa jiraSadarkaa 2
6 Months – 65 Years · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605Asciminib Roll-over Study
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 7 hanga 100 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT04877522Registry of Older Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT07638007Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.